McPherson's Ltd
ASX:MCP

Watchlist Manager
McPherson's Ltd Logo
McPherson's Ltd
ASX:MCP
Watchlist
Price: 0.18 AUD -2.7%
Market Cap: AU$25.9m

McPherson's Ltd
Investor Relations

McPherson's Ltd. operates as a supplier of health and beauty, consumer durable and household consumable products. The company is headquartered in Sydney, New South Wales. The firm's segments are Australia, New Zealand, and Rest of the World. The firm focuses on marketing and distributing beauty care, hair care, skin care and personal care items such as facial wipes, cotton pads and foot comfort products, as well as a range of kitchen essentials such as baking paper, cling wrap and aluminum foil. The firm's health and beauty brands include A’kin, Dr. LeWinn's, Lady Jayne, Glam by Manicare, Revitanail, Swisspers, Moosehead and Soulful. The firm's household consumable brand is Multix.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Feb 25, 2026
AI Summary
Q2 2026

Revenue: Group revenue fell 6.7% to $66 million, mainly due to transitional supply chain issues and reduced sales in portfolio brands.

Core Brands: Core brand revenue was broadly stable, down 1%, but grew 2.2% on a like-for-like basis excluding wholesaler rebates.

Profitability: Underlying EBITDA increased 10.6% to $2.2 million, reflecting early benefits from the new operating model.

Turning the Corner: Underlying NPAT improved to a $0.4 million loss compared to a $1.3 million loss last year.

Cash Position: Net cash rose to $12.6 million from $8.8 million, driven by strong operational cash flow.

Buyback: Announced an on-market share buyback of up to $2 million, with no interim dividend declared.

Outlook: Management expects moderate year-on-year growth in underlying FY '26 EBITDA, weighted to the second half.

Key Financials
Revenue
$66 million
Underlying EBITDA
$2.2 million
Underlying NPAT
loss of $0.4 million
Net Cash
$12.6 million
Manicare Revenue
$25.5 million
Swisspers Revenue
$11.8 million
Lady Jayne Revenue
$9.4 million
Dr LeWinn's Revenue
$8.6 million
Dr LeWinn's E-Commerce Revenue
$201,000
Fusion Health Revenue
$6.7 million
Independent Pharmacy Distribution
over 4,000 pharmacies
Annualized Route-to-Market Cost Savings
$4.5–$5 million
Share Buyback
up to $2 million
Other Earnings Calls
2026

Management

Mr. Brett Robert Charlton B.Com.
MD, CEO & Director
No Bio Available
Mr. Mark Sherwin
Chief Financial Officer
No Bio Available
Mr. Nathan Alexander
Chief Information Officer
No Bio Available
Mr. Craig Durham
General Counsel & Company Secretary
No Bio Available
Ms. Melissa Sherry
Chief Marketing Officer
No Bio Available
Ms. Hanli Pretorius
Chief People Officer
No Bio Available
David Fielding
Director of Strategy, Planning and Innovation
No Bio Available
Dawn Swainston
General Manager of Health
No Bio Available

Contacts

Address
NEW SOUTH WALES
Sydney
105 Vanessa St, Kingsgrove
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett